Role of nuclear cardiology for determining management of patients with stable coronary artery disease.
Both radionuclide angiography and myocardial perfusion imaging provide important insights that determine the management of patients with stable coronary artery disease. Both nuclear cardiology procedures have clearly demonstrated use in the noninvasvie identification of severe (left main or three-vessel) coronary artery disease and the noninvasive assessment of prognosis and thereby determine which patients should be sent to coronary angiography. Both radionuclide angiography and myocardial perfusion imaging provide prognostic information that is independent of resting left ventricular function and coronary anatomy and thereby influence the decision regarding which patients should be sent to coronary revascularization. This review considers the evidence supporting the uses of these nuclear cardiology procedures and provides suggestions regarding their cost-effective application.
Gibbons
R J
RJ
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
D003327:Coronary Disease / Q000000981:diagnostic imaging* / Q000628:therapy; D003362:Cost-Benefit Analysis; D006801:Humans; D009204:Myocardial Revascularization; D011379:Prognosis; D011875:Radionuclide Angiography